Announcements Trials
Browse Landscape

Phase

Phase 2 11Phase NA 3Phase 1/2 3Phase 4 1Phase 3 1Phase 1 1

Status

Terminated 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1Dermatologic 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 18Arthritis, Rheumatoid 4Neoplasm, Residual 3Meningeal Carcinomatosis 2Burkitt Lymphoma 2Subcutaneous panniculitis-like T-cell lymphoma 1Psoriasis 1Mycosis Fungoides 1Medulloblastoma 1Mediastinal Neoplasms 1Lymphoma, T-Cell, Cutaneous 1Lymphoma, Large-Cell, Anaplastic 1Lymphoma, Large B-Cell, Diffuse 1Lymphoma 1Leukemia, Biphenotypic, Acute 1Immunoblastic Lymphadenopathy 1Enteropathy-Associated T-Cell Lymphoma 1

Interventions

denileukin diftitox 3mogamulizumab 1Methoxsalen 1Methotrexate 1Introns 1Interferon alpha-2 1Glucose Tolerance Test 1Clorazepate Dipotassium 1Bexarotene 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 4 × Lymphoma, T-Cell, Cutaneous × Methotrexate × Clear all
NCT02323659 2022-01-13

Comparison of Methotrexate Versus Interferon-alfa 2b in Patients With Primary Cutaneous T-cell Lymphomas

Polish Lymphoma Research Group

Phase 4 Terminated
100 enrolled
DermatologicLymphoid

Mycosis Fungoides, Lymphoma, T-Cell, Cutaneous

Data powered by HemOnc (CC BY 4.0) Colophon âš¡